» Articles » PMID: 35654881

Transient Expression of an Adenine Base Editor Corrects the Hutchinson-Gilford Progeria Syndrome Mutation and Improves the Skin Phenotype in Mice

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Jun 2
PMID 35654881
Authors
Affiliations
Soon will be listed here.
Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature ageing disorder caused by a point mutation in the LMNA gene (LMNA c.1824 C > T), resulting in the production of a detrimental protein called progerin. Adenine base editors recently emerged with a promising potential for HGPS gene therapy. However adeno-associated viral vector systems currently used in gene editing raise concerns, and the long-term effects of heterogeneous mutation correction in highly proliferative tissues like the skin are unknown. Here we use a non-integrative transient lentiviral vector system, expressing an adenine base editor to correct the HGPS mutation in the skin of HGPS mice. Transient adenine base editor expression corrected the mutation in 20.8-24.1% of the skin cells. Four weeks post delivery, the HGPS skin phenotype was improved and clusters of progerin-negative keratinocytes were detected, indicating that the mutation was corrected in both progenitor and differentiated skin cells. These results demonstrate that transient non-integrative viral vector mediated adenine base editor expression is a plausible approach for future gene-editing therapies.

Citing Articles

Endothelial cell-specific progerin expression does not cause cardiovascular alterations and premature death.

Benedicto I, Hamczyk M, Nevado R, Barettino A, Carmona R, Espinos-Estevez C Aging Cell. 2024; 24(2):e14389.

PMID: 39479939 PMC: 11822624. DOI: 10.1111/acel.14389.


Protein isoform-centric therapeutics: expanding targets and increasing specificity.

Kjer-Hansen P, Phan T, Weatheritt R Nat Rev Drug Discov. 2024; 23(10):759-779.

PMID: 39232238 DOI: 10.1038/s41573-024-01025-z.


Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.

Benedicto I, Carmona R, Barettino A, Espinos-Estevez C, Gonzalo P, Nevado R Proc Natl Acad Sci U S A. 2024; 121(18):e2400752121.

PMID: 38648484 PMC: 11066978. DOI: 10.1073/pnas.2400752121.


Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover.

Foo M, Ong P, Yap Z, Maric M, Bong C, Droge P Aging Cell. 2024; 23(5):e14105.

PMID: 38504487 PMC: 11113360. DOI: 10.1111/acel.14105.


Premature aging in genetic diseases: what conclusions can be drawn for physiological aging.

Milosic F, Hengstschlager M, Osmanagic-Myers S Front Aging. 2024; 4:1327833.

PMID: 38481648 PMC: 10933081. DOI: 10.3389/fragi.2023.1327833.


References
1.
Waseem A, Dogan B, Tidman N, Alam Y, Purkis P, Jackson S . Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol. 1999; 112(3):362-9. DOI: 10.1046/j.1523-1747.1999.00535.x. View

2.
Santiago-Fernandez O, Osorio F, Quesada V, Rodriguez F, Basso S, Maeso D . Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome. Nat Med. 2019; 25(3):423-426. PMC: 6546610. DOI: 10.1038/s41591-018-0338-6. View

3.
Stables G, Morley W . Hutchinson-Gilford syndrome. J R Soc Med. 1994; 87(4):243-4. PMC: 1294455. View

4.
Plasilova M, Chattopadhyay C, Pal P, Schaub N, Buechner S, Mueller H . Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet. 2004; 41(8):609-14. PMC: 1735873. DOI: 10.1136/jmg.2004.019661. View

5.
Erdem N, Gunes A, Avci O, Osma E . A case of Hutchinson-Gilford progeria syndrome mimicking scleredema in early infancy. Dermatology. 1994; 188(4):318-21. DOI: 10.1159/000247175. View